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Department of Biomedical Engineering, The University of Alabama, Birmingham, AlabamaABSTRACT N-glycosylation of the I-like domain of b1 integrin plays an essential role in integrin structure and function, and the
altered sialylation of b1 integrin regulates b1 integrin binding to ﬁbronectin. However, the structural basis underlying the effect of
altered sialylation of the b1 I-like domain on b1 integrin binding to ﬁbronectin remains largely unknown. In this study, we used
a combination of molecular dynamics simulations and binding free energy analyses to investigate changes in binding thermody-
namics and in conformation of the glycosylated b1 I-like domain-FN-III9-10 complex caused by altered sialylation of the b1 I-like
domain. Binding free energy analyses showed that desialylation of b1 I-like domain increased b1 integrin binding to ﬁbronectin,
consistent with experimental results. Interaction analyses showed that altered sialylation of the b1 I-like domain resulted in signif-
icant changes in the interaction of the N-glycans of the I-like domain with both the I-like domain and ﬁbronectin, and these
changes could directly affect the allosteric regulation of the interaction between the I-like domain and ﬁbronectin. Altered sialy-
lation of the b1 I-like domain caused signiﬁcant conformational changes in key functional sites of both the b1 I-like domain and
ﬁbronectin. In addition, altered sialylation of the b1 I-like domain resulted in changes in the degree of correlated motions between
residues in the I-like domain and residues in ﬁbronectin, and in the degree of motion changes in ﬁbronectin, which could affect b1
integrin binding to ﬁbronectin. We believe results from this study provide thermodynamic and structural evidence for a role of
altered sialylation of b1 integrin in regulating b1 integrin binding to ﬁbronectin and it’s induced cellular activities.INTRODUCTIONCell adhesion, regulated by interactions between the cell and
the extracellular matrix (ECM), plays an important role in
cellular functions such as cell growth, migration, differenti-
ation, and proliferation (1). Studies have shown that interac-
tions between the transmembrane glycoprotein a5b1 integrin
and the extracellular matrix protein fibronectin are funda-
mental for vertebrate development and have been suggested
to be involved in cardiovascular events and tumor invasion
(2–6). N-glycosylation of a5b1 integrin is required for ab
heterodimer formation and for the interaction between
a5b1 integrin and fibronectin (7–12). Desialylation of
a5b1 integrin leads to increased adhesion to fibronectin,
affecting cell adhesion and differentiation in myeloid cells
(11,13). The I-like domain of b integrin, a region crucial
for ligand binding (14), carries N-glycans attached to Asn-
192, Asn-249, and Asn-343 (13). A recent study has shown
the essential role of N-glycosylation of the I-like domain of
b1 integrin for a5b1 integrin expression, heterodimer forma-
tion, and fibronectin-mediated biological functions,
including cell adhesion and cell spreading (7). The I-like
domain of b1 integrin contains the critical functional sites
required for ligand binding, including the specificity-deter-
mining loop (SDL) (15), the metal ion-dependent adhesion
site containing a DLSYS motif (16,17), the a1 and a7
helices (18), and other critical residues (Asn-224, Asp-226,Submitted August 13, 2009, and accepted for publication March 22, 2010.
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0006-3495/10/07/0208/10 $2.00Glu-229, Asp-233, Asp-267, and Asp-295) (19). Our recent
molecular dynamics (MD) study regarding the effects of
altered sialylation on the structure of the I-like domain of
b1 integrin shows that altered sialylation of the b1 I-like
domain changes the interactions between glycans and the
I-like domain, affects accessibility of the SDL region for
ligand binding, and results in significant conformational
changes in most of the key functional regions of the b1
I-like domain involved in ligand binding (20).
The extracellular matrix protein fibronectin (FN) is
a ligand for a large number of different integrins, including
a5b1 integrin (21,22). For the integrin-FN complex, fibro-
nectin not only provides a substrate for cell anchorage to
the ECM, but also serves as a regulatory factor in many
cellular processes including cell adhesion, growth, migra-
tion, differentiation, and proliferation (1). Structurally, fibro-
nectin is a multimodular extracellular protein composed of
>20 modules per monomer. The structure of fibronectin is
rod-like, and is composed of three different types of homol-
ogous, repeating modules, type I (FN-I), type II (FN-II), and
type III (FN-III) (21). FN-III module 10 (FN-III10) contains
the RGD (Arg-Gly-Asp) sequence required for specific
recognition by integrins (21). In addition to the RGD
sequence, fibronectin also contains a synergy site that selec-
tively enhances binding of certain integrins to the neigh-
boring RGD loop (23,24). Some specific integrins, including
a5b1, can recognize both the synergy site and RGD-loop of
FN. One apparent function of the synergy site is to allow in-
tegrin a5b1 to bind to FN preferentially over other RGD-
containing matrix proteins (25–27). Previous studies havedoi: 10.1016/j.bpj.2010.03.063
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N-glycosylation of b1 integrin (7,11,13). The structure of the
FN-III repeats, including the seventh through the synergy
region-containing ninth and the RGD-containing tenth
repeats, has been crystallized successfully (28), providing
a basis for structural studies of fibronectin interactions with
glycosylated a5b1integrin.
The molecular and structural basis for the effect of the
altered sialylation of the b1 I-like domain on a5b1 integrin
binding to fibronectin remains unclear. In this study, we
used a combination of explicit solvent MD simulations and
implicit solvent binding free energy analyses to investigate
changes in binding thermodynamics, conformation and
motion of the glycosylated b1 I-like domain-FN-III9-10
complex caused by altered sialylation of b1 I-like domain.
Results from this study provide thermodynamic and struc-
tural evidence for the role of altered sialylation of b1 integrin
in regulating the interaction of b1 integrin and fibronectin
and its induced cellular activities.RESULTS AND DISCUSSION
Materials and methods for model of the glycosylated bI-like
domain-fibronectin complex, molecular dynamics simula-
tions, binding free energy analyses, interaction analyses,
conformational and motion analyses, and statistical methods
are detailed in the Supporting Material.Constructed model of the glycosylated b1 I-like
domain-ﬁbronectin complex
With the choice of a relatively simple biantennary complex
carbohydrate with the same composition used in our
previous study (20), along with a well developed and vali-
dated force field for carbohydrates (29), using the enhanced
sampling techniques of a simulated annealing and replica
exchange MD simulation (REMD) (Supporting Material),
we obtained an adequately sampled conformation of the
oligosaccharide (Fig. 1 A). The convergence of REMD simu-
lation for oligosaccharide was evaluated through the cluster
population analysis method (30), by comparing the popula-
tions of the clusters between the two independent REMD
simulations with different initial conformations. The popula-
tions of the clusters in each ensemble were highly correlated
(a correlated coefficient of R2 ¼ 0.956 and a slope of 1.08)
(Fig. S1). The highly correlated populations of the clusters
between the two independent REMD simulations indicated
that the relative population of the conformation of oligosac-
charide is highly converged. Using the crystal structure of
the extracellular segment of integrin avb3 in complex with
an RGD ligand (PDB ID: 1L5G) as a template, we con-
structed a model for the b1 I-like domain in complex with
an RGD ligand using the MODELER 9v2 homology
modeling package (31) (Supporting Material) (Fig. 1 B).
We evaluated the constructed model of the b1 I-like domainin complex with the RGD ligand with PROCHECK (32),
ERRAT (33), and WHATCHECK (34). The evaluation
results of the constructed model of the b1 I-like domain in
complex with the RGD ligand were very similar to the
template crystal structure (Table S1), suggesting a valid
structure for the constructed model. The complex of the b1
I-like domain with FN-III9-10 was then constructed by replac-
ing the RGD ligand in the constructed complex with the
RGD region of the crystal structure of FN-III10 with geomet-
rical fitting (Supporting Material). The orientation of
FN-III9-10 was adjusted with the RGD region fixed to avoid
any steric clashes between the b1 I-like domain and FN-III9-
10, as carried out in a previous study (35). The fully sampled
glycan was covalently linked to the amide nitrogens of Asn-
192, Asn-249, and Asn-343 of the b1 I-like domain-fibro-
nectin complex using VMD software (36) to obtain the
glycosylated I-like domain-fibronectin complex (Fig. 1 C).
Due to the uncertainty of the exact orientations of N-glycans
relative to the b1 I-like domain and the highly flexible nature
of the glycans (37), we constructed five pairs of glycosylated
I-like domain-fibronectin complexes with sialic acid and
without sialic acid with different starting orientations of the
glycans relative to the I-like domain to obtain statistically
meaningful results. Equilibration of the simulated systems
is detailed in the Supporting Material.Binding thermodynamics analysis
Experiments show that desialylation of b1 integrin enhances
the interaction between b1 integrin and fibronectin (11,13).
To validate the constructed glycosylated b1 I-like domain-
fibronectin complex and simulation results, we calculated
the binding free energy changes of the glycosylated b1
I-like domain-fibronectin complex by the desialylation of
b1 I-like domain and qualitatively compared these results
to experimental results about the tendency for the effect of
hyposialylation of a5b1 integrins on its binding to fibro-
nectin. The calculated binding free energy results, including
the energy components contributing to the binding free
energy, were calculated using the last 35 ns of simulation
trajectories of the five sets of MD simulations that had
different initial N-glycan orientations (see Table 1 for the
results averaged over the five sets of MD simulations, and
for the results of each individual set of MD simulations).
From the 15 ns–50 ns simulation trajectories of the five
sets of MD simulations, the mean of the binding free energy
was obtained by averaging over trajectories, and the standard
deviation was calculated with the independent periods of the
MD simulation trajectories, using the bootstrap statistics
method described in the Materials and Methods section of
the Supporting Material. The autocorrelation time used to re-
sample the MD simulation trajectories was calculated based
on the binding free energy complexes of the b1 I-like domain
and fibronectin as a function of cumulative time over the
50 ns MD simulations. The independent conformationalBiophysical Journal 99(1) 208–217
FIGURE 1 (A) Conformation of the N-linked
oligosaccharide with a2-6 sialic acid (ASO). (B)
Superposition of the homology built I-like domain
b1 integrin in complex with the RGD ligand and
crystal structure of I-like domain of b3 integrin in
complex with RGD ligand. (C) Model of the glyco-
sylated I-like domain of b1 integrin in complex
with the crystal structure of FN-III9-10. The images
were made with VMD software support.
210 Pan and Songregion of the glycosylated I-like domain and fibronectin
complexes were further displayed in the pairwise backbone
RMSD matrix for the entire glycosylated I-like domain and
fibronectin complex structure (Fig. S5). The RMSD matrix
showed four blue squares along diagonal of the RMSD
matrix for the system without sialic acid (Fig. S5 A), and
also showed four blue squares along diagonal of the
RMSD matrix for the system with sialic acid (Fig. S5 B).
The blue represented low RMSD, whereas red represented
high RMSD, and each blue square along the diagonal
represented an independent conformational region. The
calculated results showed that desialylation of the b1 I-like
domain resulted in a decreased binding free energy of
12.4 5 5.2 kcal/mol, indicating that desialylation of the
b1 I-like domain has a positive effect on the binding between
b1 integrin and fibronectin. The experimental studies
showed that hyposialylation of a5b1 integrins stimulates
the activity of myeloid fibronectin receptors (11) and the
enzymatic removal of sialic acids from purified a5b1 integ-
rins increases a5b1 integrins binding to fibronectin (13). The
calculated results of the positive effect of desialylation of the
b1 I-like domain on the binding between b1 integrin andBiophysical Journal 99(1) 208–217fibronectin were qualitatively consistent with the experi-
mental observations about the positive effect of hyposialyla-
tion of a5b1 integrins on its binding to fibronectin (11,13).
Based on changes in the energy components contributing
to the binding free energy, the change in binding free energy
of the complex caused by desialylation could result from one
or more possibilities. These possibilities include the change
in charge caused by desialylation (sialic acid has a 1e
charge), changed interactions of glycans with the I-like
domain and fibronectin and the conformational changes in
the I-like domain and fibronectin by the changed allosteric
regulation by the glycans with different degree of sialylation.
After the qualitative validation of the calculated results
regarding the positive effect of desialylation of the b1
I-like domain on the b1 integrin-fibronectin binding with
the experimentally observed positive effect of hyposialyla-
tion of a5b1 integrins on its binding to fibronectin, we
further analyzed the effects of altered sialylation on changes
in interaction of glycans with the I-like domain and fibro-
nectin and the conformational and motion changes of the
I-like domain and fibronectin in the glycosylated b1 I-like
domain-fibronectin complexes.
TABLE 1 Calculated binding free energy for glycosylated
b1 I-like domain-ﬁbronectin complex (kcal/mol)
With a2-6 sialic
acid (3ASO)
Without a2-6 sialic
acid (3ANS)
DEelectrostatic 383.55 23.9 408.75 28.8
DEvdW 98.25 3.5 104.05 5.4
DGsolvation-polar 447.55 23.8 463.25 28.4
DGsolvation-nopolar 16.45 0.8 18.15 0.7
DTS 37.25 3.6 41.85 3.3
DGbinding 13.45 4.5 25.85 5.8
DDGbinding 12.45 5.2*
Experimental result (11) Weaker Strong
All the mean values in this table were averaged over the five sets of MD
simulation trajectories and the standard deviations were obtained based
on the averages of all resamples datasets from five sets of MD simulation
trajectories using bootstrap method. DEvdW is the van der Waals energy,
DEelectrostatic is the electrostatic energy, DGsolvation-polaris the polar solvation
energy,DGsolvation-nopolar is the nonpolar solvation energy,DTS is the energy
contributed from solute entropy, DGbinding is the binding free energy for the
complex, and DDGbinding is the relative binding free energies with respect to
the complex without sialic acid. *Differences are statistically significant
(Student’s t-test, p < 0.05).
FIGURE 2 Hydrogen bonds formed between the glycans of the I-like
domain with the (A) b1 I-like domain and (B) FN-III9-10. 3ANS, glycosyla-
tion without sialic acid; 3ASO, glycosylation with sialic acid.
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domain with the b1 I-like domain-ﬁbronectin
complex
The glycans of the glycoprotein are highly flexible (37), and
the glycans of the I-like domain appeared to interact with the
b1 I-like domain and fibronectin during the dynamics simu-
lations, shown by the formation of hydrogen bonds not only
with the I-like domain (Fig. 2 A), but also with fibronectin
(Fig. 2 B). A hydrogen bond was assigned when the distance
of hydrogen and acceptor was <3.5 A˚, and the angle of
acceptor/donor/hydrogen was >150. OH and NH groups
were treated as donors, oxygen or nitrogen was defined as
acceptor. With respect to the interactions between the
glycans and the I-like domain, the mean and standard devia-
tion of the number of hydrogen bonds obtained from the five
independent pairs of MD simulations showed that desialyla-
tion of the glycans resulted in significantly decreased
hydrogen bond formation between the glycans and the
I-like domain (p< 0.05) (Fig. 2 A). With respect to the inter-
actions between the glycans of the I-like domain and fibro-
nectin, hydrogen bonds were formed only for the glycans
attached to Asn-192 and Asn-343, which are located close
to the binding region of the I-like domain with fibronectin
(Fig. 1 C) (Fig. 2 B). The mean and standard deviation of
the number of hydrogen bonds calculated from the trajecto-
ries of five sets of MD simulations showed that desialylation
of the glycans resulted in significantly decreased hydrogen
bond formation between the glycan at Asn-343 and fibro-
nectin (p < 0.05) (Fig. 2 B). The change in interactions
between the glycans and the I-like domain and fibronectin
caused by altered sialylation could directly result in a change
in allosteric regulation of the interaction between the I-like
domain and fibronectin, which involves changes in the
conformation of the proteins, changes in the degree of corre-lated motions between residues, and changes in residue
motion within the residues of the proteins in the complex.Conformational changes in the b1 I-like domain
We calculated the mean and standard deviation for the root
mean-square deviation (RMSD) of the critical functional
sites of the b1 I-like domain, including the SDL, the metal
ion-dependent adhesion site containing a DLSYS motif,
and other critical residues (Asn-224, Asp-226, Glu-229,
Asp-233, Asp-267, and Asp-295) (15–19) for the systems
with and without sialic acid (Table S3). The reference struc-
ture for RMSD calculations was the initial structure of the
I-like domain, and the average and standard deviations of
the RMSD for the key functional sites were calculated using
the trajectories of the five sets of independent MD simula-
tions. Results showed that altered sialylation of the b1
I-like domain resulted in significant conformational changesBiophysical Journal 99(1) 208–217
212 Pan and Songfor half of the key functional sites of the b1 I-like domain
(Student’s t-test, p < 0.05). Experimental studies have
shown that movement of the a1 and a7 helices is directly
involved in integrin activation (18,38,39). Analysis of the
movement of the centers of mass of the a1 and a7 helices
showed that altered sialylation of the b1 I-like domain
caused significant movement of the a1 and a7 helices
(p < 0.05) (Fig. 3). These conformational changes in the
I-like domain might result from the changes in interactions
between glycans and the I-like domain-fibronectin complex
or changes in allosteric regulation caused by glycans with
altered sialylation. The calculated results regarding the
conformational changes in the b1 I-like domain caused by
altered sialylation were consistent with the results from our
previous study (20) and could contribute to the experimen-
tally observed changes in binding between b1 integrin and
fibronectin (11,13).
Conformational changes in ﬁbronectin
RGD conformational change
The RGD loop is the specific binding region of fibronectin
for integrin (21). Experimental studies show that the confor-
mation of RGD directly affects the binding specificity of
RGD in cell adhesion (40–42). Furthermore, the distance
from the RGD region to the FN-III10 core could affect the
accessibility of RGD to integrin for integrin activation
(43,44). The crystal structure of fibronectin shows that the
RGD loop is located at the apex of a hairpin b-turn connect-
ing strands F and G (28). We calculated the conformation of
the RGD-containing loop for the glycosylated I-like domain-
fibronectin complex systems with and without sialic acid
using the five sets of independent MD simulations trajecto-
ries to determine the effect of altered sialylation on RGD
conformational changes. Similar to previous studies quanti-
fying the conformation of the RGD-containing loop under
external force (44,45), we measured the distance from the
RGD segment to the FN-III10 core by calculating the vertical
distance from the Ca atom of Asp-1495 (at the apex of RGDFIGURE 3 Z-coordinates of the center of mass for a1 and a7 helices.
Biophysical Journal 99(1) 208–217loop) to the plane defined by the residues Val-1487 and Ala-
1489 on the F strand and the residue Arg-1448 on the C
strand (the C and F strands serve as the substrate surface
of the RGD loop in fibronectin FN-III10) (Fig. 4, A and C).
We also calculated the bend angle of the RGD region defined
by the Ca atoms of residues Asp-1495 and Arg-1493 in RGD
and residue Thr-1491 in the F strand (Fig. 4, B and D). The
results showed that desialylation of the I-like domain in the
glycosylated I-like domain-fibronectin complex caused an
increase in distance between the RGD region and the
FN-III10 core from 13.5 5 1.8 A˚ to 16.1 5 0.6 A˚ (Fig. 4
C). Experimental results have shown that distances ranging
from 11 A˚ to 3.0 A˚ between RGD and the FN-III10 core
are optimal for RGD binding (43). The calculated distances
between RGD and the FN-III10 core for the systems with and
without sialic acid were all in the allowable binding range
suggested by experimental results (43). However, the
increased distance between RGD and the FN-III10 core
caused by desialylation of the I-like domain could increase
the accessibility of RGD to membrane-bound integrin and
enhance their interaction. The desialylation of the I-like
domain also resulted in a changed bend angle of the RGD
loop from 1515 2.4 to 1465 2.3 (Fig. 4 D). The confor-
mational changes in RGD caused by altered sialylation of the
I-like domain in the glycosylated I-like domain-fibronectin
complex could contribute to differences in binding of fibro-
nectin to integrin observed in experimental systems (11,13).
The calculated conformational changes in the RGD loop
caused by altered sialylation were also observed in the
force-regulated conformational changes of RGD (44,45).
These observations suggest that functional mediation of
cell adhesion with external force might also be implemented
through regulation of sialylation of the b1 I-like domain.
Interactive conformational changes in the RGD-synergy site
a5b1 integrin binds to both the RGD and the synergy sites of
fibronectin, and the synergy site allows a5b1 integrin to bind
to fibronectin preferentially over other RGD-containing
matrix proteins (23–27). Experimental studies have sug-
gested that the relative conformational changes between
the RGD loop and synergy site play a critical role in the inter-
action between a5b1 integrin and fibronectin (46–48). We
calculated the relative rotational orientation and the distance
between the RGD loop and synergy site for the systems with
and without sialic acid based on the five pairs of MD simu-
lation trajectories. Similar to the definition of the relative
rotational orientation and the distance between the RGD
and synergy sites in a previous study (49), we defined the
relative rotational orientation as a dihedral angle formed by
the Ca atoms of residues Arg-1379 in FN-III9, Arg-1493 in
FN-III10, and the centers of mass of FN-III9 and FN-III10.
The distance between RGD and the synergy site was defined
to be the distance between the Ca atoms of Arg-1379 on the
synergy site and Arg-1493 on the RGD loop in fibronectin
(Fig. 5 A). The calculated results showed that desialylation
FIGURE 4 (A) Definition of the distance of the RGD segment to the FN-III10 core, measured from the Ca atom of Asp-1495 to the plane defined by the
residues Val-1487 and Ala-1489 on the F strand and the residue Arg-1448 on the C strand. (B) Definition of the bend angle of RGD: angle formed by the
Ca atoms of residues Asp-1495 and Arg-1493 in RGD and residue Thr-1491 in the F strand. (C) Distance of the RGD segment to the FN-III10 core. (D)
Bend angle of RGD.
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nectin complex caused a significant increase in the torsion
angle from 25.95 2.8 to 32.65 3.1 (Fig. 5 B) (Student’s
t-test, p < 0.05), and resulted in a significant decrease in
distance between RGD and the synergy site from 39.2 5
2.2 A˚ to 34.6 5 1.2 A˚ (Student’s t-test, p < 0.05). The
crystal structure of FN-III7-10 shows that Arg-1379 on the
synergy site and Arg-1493 on the RGD loop are separated
by ~32 A˚ (28), which is optimal for fibronectin binding to
a5b1 integrin (23,47). Furthermore, Arg-1379 in the synergy
site is a key residue for binding to integrin (48). The calcu-
lated distance between the RGD loop and the synergy region
for the system without sialic acid is closer than the system
with sialic acid to the experimentally observed optimal
distance for fibronectin binding to a5b1 integrin, consistent
with experimental results regarding the effect of desialyla-
tion of b1 integrin on enhancement of b1 integrin bindingto fibronectin (11,13). Experimental results also showed
that the spatial positioning of the RGD loop and synergy
site, including the distance between RGD and the synergy
site and the twist and tilt angles between FIII9 and FIII10, is
critical for fibronectin binding to integrin to signal cell adhe-
sion (23). Altered sialylation of b1 integrin has been shown to
affect b1 integrin binding to fibronectin and further influence
cell adhesion (11,13). The results of the calculated changes in
distance and orientation of the RGD loop relative to the
synergy site caused by altered sialylation of the b1 I-like
domain may contribute to the experimentally observed
changes in fibronectin binding tob1 integrin caused by altered
sialylation of b1 integrin (11,13). These results are consistent
with experimental observations regarding the critical role of
spatial positioning of the RGD loop and synergy site in cell
adhesion (23). The calculated interactive conformational
changes of the RGD and synergy site, which are importantBiophysical Journal 99(1) 208–217
FIGURE 5 (A) Definition of the distance and torsion dihedral angle between the RGD loop and the synergy site. Distance was defined by the Ca atoms of Arg-
1379 on the synergy site and Arg-1493 on the RGD loop. The torsion angle was defined by the Ca atoms of Arg-1379, Arg-1493, and the center of masses of
FN-III9 and FN-III10. (B) Relative rotational orientation between the RGD loop and the synergy site. (C) Distance between the RGD loop and the synergy site.
214 Pan and Songfor b1 integrin binding to fibronectin, were also observed in
the force regulation of integrin binding to the RGD and
synergy site of fibronectin (49,50). This indicates that altered
sialylation of the b1 I-like domain may play a similar role to
external force in regulation of the b1 integrin/fibronectin
interaction and mediation of cellular adhesion events.Motion changes in the b1 I-like domain
and ﬁbronectin
Dynamical cross-correlation maps investigate the degree of
correlated motions between the residues in the protein, whichFIGURE 6 Dynamical cross-correlation maps for the degree of correlated moti
I-like domain without sialic acid (top left) compared to the I-like domain with sia
residues 170–210 and residues 260–320, and between residues 220–260 and resi
170–230 and residues 320–360, and between residues 260–320 and residues 320
compared to the system with sialic acid (bottom right) (squared regions show the
and residues 1416–1509, between residues 1370–1400 and residues 1416–1509; c
the RGD loop (residues 1493–1495) in FN-III10 and the synergy site in FN-III9 (r
For map in grayscale, white, correlation; black, anticorrelation.)
Biophysical Journal 99(1) 208–217could provide further insight into the effects of the altered
sialylation of the I-like domain on b1 integrin binding to
fibronectin (Fig. 6). Fig. 6 A shows the cross-correlation
maps for the I-like domain without sialic acid (top left
half) and with sialic acid (bottom right half). The maps
showed that desialylation of the I-like domain resulted in
an overall decreased degree of correlated motion, and an
increased degree of anticorrelated motion within the residues
of the I-like domain. Specifically, desialylation of the I-like
domain caused a decreased degree of correlated motion
between residues 170–210 and residues 260–320, and
between residues 220–260 and residues 260–320 (squaredon of the residues in the glycosylated I-like domain-fibronectin complex. (A)
lic acid (bottom right) (squared regions show the correlated motion between
dues 260–320; circled regions show the correlated motion between residues
–360). (B) Fibronectin for the complex system without sialic acid (top left)
degree of correlated and anticorrelated motions between residues 1326–1360
ircled regions show the degree of correlated motion between regions around
esidues 1376–1380)). (For color map, red, correlation; blue, anticorrelation.
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tional sites in the I-like domain, such as residues in the
SDL region (residues 170–197) and a7 helix (residues
344–355), and binding-related critical residues N224,
D226, E229, D233 (within residues 220–260) and D267,
D295 (within residues 260–320). Desialylation of the I-like
domain also resulted in an increased degree of anticorrelated
motion between residues 170–230 and residues 320–360,
and between residues 260–320 and residues 320–360
(circled in Fig. 6 A). These results indicate that desialylation
of the I-like domain directly affects the degree of correlated
motions between residues, including critical functional sites,
which may contribute to changes in the binding of b1 integ-
rin to fibronectin.
Dynamical cross-correlation maps for fibronectin within
the glycosylated I-like domain-fibronectin complex without
sialic acid (top left half) and with sialic acid (bottom right
half) are shown in Fig. 6 B. In the complex lacking sialyla-
tion, the degree of correlated motion between residues within
FN-III9 and within FN-III10 was not significantly changed,
but the correlated and anticorrelated motion between resi-
dues in FN-III9 and residues in FN-III10 was significantly
changed. Specifically, the degree of correlated and anticorre-
lated motions between residues 1326–1360 and residues
1416–1509, and also between residues 1370–1400 and resi-
dues 1416–1509 (squared) was significantly decreased,
including the degree of correlated motion between regions
surrounding the RGD-loop in FN-III10 (residues 1493–
1495) and the synergy site in FN-III9 (residues 1376–
1380) (circled). The RGD and synergy site cooperate with
one another for recognition by a5b1 integrin (23–27). The
change in degree of correlated motions between residues in
FN-III9 and residues in FN-III10 caused by the altered sialy-
lation of the I-like domain in the glycosylated I-like domain-
fibronectin complex, particularly for the residues between
the RGD-loop and synergy site, could directly contribute
to changes in the binding between fibronectin and a5b1 in-
tegrin observed in previous experiments (11,13).
We also analyzed the dynamics of the system using prin-
cipal component analysis (PCA), which uses a few nanosec-
onds of MD simulation trajectories to assess the primary
motions of the system that occurred at a longer timescale
(51). The primary motion of the system is usually repre-
sented by the relatively lower frequency modes obtained
from PCA, and the first PCA mode is usually interpreted
as the direction of the largest conformational fluctuation of
the system during MD simulations (52,53). Each PCA
mode is associated with an eigenvalue that corresponds to
the amplitude of fluctuations along that mode, and each
eigenvalue normalized by the sum of all eigenvalues can
represent the relative contribution of a mode to the dynam-
ical motion of the selected atoms observed in the MD simu-
lation (54). Based on the five pairs of independent MD
simulation trajectories, the distribution of the relative contri-
bution of the first ten PCA modes of the I-like domain withand without sialic acid is shown in Fig. S6 A. The result indi-
cated that the contribution of each PCA mode to the motion
of the I-like domain was not significantly changed by desia-
lylation. However, the PCA analysis for fibronectin showed
that the desialylation of the I-like domain resulted in an
increased contribution of the first mode to the dynamical
motion of fibronectin from 57.8% (with sialic acid) to
67.1% (without sialic acid) (Fig. S6 B). The motion direc-
tions of the first PCA mode for the systems with and without
sialic acid were shown on the atomic structure of the glyco-
sylated I-like domain-Fn complexes (Fig. S7). The compar-
ison of the direction and amplitude of the first PCA mode
between the systems without sialic acid (Fig. S7 A) and
with sialic acid (Fig. S7 B) showed that the direction and
amplitude of the first PCA mode in I-like domain did not
exhibit obvious difference. However, differences of the
motion amplitude and direction of the first PCA mode in
fibronectin were observed, particularly in the FN_III9
module, the first PCA mode in the system with sialic acid
(3ASO) showed a larger motion amplitude and more disper-
sive motion direction compared to the system without sialic
acid (3ANS). These motion changes are expected to be func-
tionally relevant to the experimental observation that altered
sialylation of b1 integrin affects the binding of fibronectin to
b1 integrin (11,13).CONCLUSIONS
In this study, we characterized the conformation of a rela-
tively simple biantennary complex carbohydrate using the
enhanced sampling technique, and constructed a validated
model of the glycosylated b1 I-like domain- FN-III9-10
complex. We carried out five pairs of independent MD simu-
lations for the glycosylated I-like domain-fibronectin
complexes with and without sialic acid in the N-linked
glycans of the I-like domain, with different initial orienta-
tions of the N-linked glycans relative to the b1 I-like domain.
The calculated results about the positive effect of the desia-
lylation of b1 I-like domain on the b1 integrin-fibronectin
binding were qualitatively consistent with the experimental
observation about the positive effect of hyposialylation of
a5b1 integrins on its binding to fibronectin (11,13). Altered
sialylation of the b1 I-like domain resulted in significant
changes in interactions of N-glycans of the I-like domain
with both the I-like domain and fibronectin. Altered sialyla-
tion of the b1 I-like domain caused significant changes in the
conformations of key functional sites of the b1 I-like domain
and the RGD loop in FN-III10, and also changes in the rela-
tive orientation between the RGD loop and the synergy site
in FN-III9, which is critical for b1 integrin binding to fibro-
nectin. A change in the degree of correlated motions between
residues in the I-like domain and residues in fibronectin, and
a change in the degree of motion of FN-III9-10 caused by
altered sialylation of the I-like domain were also observed.
These results provide important structural insights into theBiophysical Journal 99(1) 208–217
216 Pan and Songeffect of altered sialylation of the b1 I-like domain on the
binding of b integrin to fibronectin observed in experimental
systems. Although the constructed model of a relatively
simple biantennary complex carbohydrate was representa-
tive and limited by the lack of exact structural information
on glycans, results from this study provide clear structural
information regarding the effects of altered sialylation on
the interaction between b1 integrin and fibronectin. These
results also represent a potential avenue for the identification
of novel strategies and drugs that perturb the integrin glycan
profile, regulating b1 integrin binding to fibronectin, and
potentially modulating cell adhesion in pathologic condi-
tions such as cancer and cardiovascular diseases.SUPPORTING MATERIAL
Methods, three tables, and seven figures are available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(10)00430-3.
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